Discovery and Evaluation of 4-(2-(4-chloro-1<i>H</i>-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)pyridin-2(1<i>H</i>)-one (BMS-695735), an Orally Efficacious Inhibitor of Insulin-like Growth Factor-1 Receptor Kinase with Broad Spectrum in Vivo Antitumor ActivityUpender Velaparthi, Dolatrai M. Vyas, Francis Y. Lee et al.|Journal of Medicinal Chemistry|2008Cited by 33
Design and Synthesis of 4-Heteroaryl 1,2,3,4-Tetrahydroisoquinolines as Triple Reuptake InhibitorsShuang Liu, John E. Macor, Congxiang Zha et al.|ACS Medicinal Chemistry Letters|2014Cited by 17